This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial, Journal of Medicine and Life, November 2023, Fundatia Jurnalului Journal of Medicine and Life,
DOI: 10.25122/jml-2023-0317.
You can read the full text:
The following have contributed to this page
